Characteristics of gut microbiota of term small gestational age infants within 1 week and their relationship with neurodevelopment at 6 monthsOriginal paper
What was studied?
This study examined the early-life gut microbiota of term small for gestational age (SGA) infants compared with appropriate for gestational age (AGA) infants. Fecal samples were collected on days 1, 3, 5, and 7 of life and analyzed using 16S ribosomal DNA amplicon sequencing. The researchers then followed the SGA infants for 6 months to assess whether early gut microbiota characteristics related to neurodevelopmental outcomes. The work was motivated by prior evidence that gut microbiota in early life can influence later neurodevelopment, a relationship that had been little studied in SGA populations specifically.
Who was studied?
A total of 162 term neonates born at Peking University First Hospital between June 2020 and June 2021 were enrolled. Of these, 41 infants (25.3%) were classified as SGA and made up the study group, while 121 infants (74.7%) were classified as AGA and served as the control group. Neurodevelopmental outcomes at 6 months were assessed among the SGA infants using the Ages and Stages Questionnaires-3 (ASQ-3).
What were the most important findings?
Gut microbial diversity was consistently lower in the SGA group than in the AGA group on days 1, 3, 5, and 7 after birth. Non-metric multidimensional scaling and analysis of similarities showed significant differences in the overall composition of the gut microbiota between the two groups. These findings indicate that being born small for gestational age is associated with a distinct and less diverse early gut microbial community from the first days of life.
What are the greatest implications of this study?
The findings support the idea that SGA status shapes the gut microbiota from the earliest days of life, in a pattern distinguishable from AGA infants. Because the study also tracked neurodevelopment at 6 months using the ASQ-3, it points toward the gut microbiota as a possible early biological marker linked to the neurodevelopmental risks already known to affect SGA infants. This underscores the value of monitoring gut microbiota composition in SGA newborns as a potential avenue for identifying infants who may benefit from closer developmental follow-up.